Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)

NCT03384875 is registered in ClinicalTrials.gov with CytoSorbents, Inc as lead sponsor.

NCT NCT03384875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03384875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)
Lead sponsor
CytoSorbents, Inc
Phase
Not applicable
Overall status
Terminated
Start date
April 19, 2018
Completion date
January 18, 2022
Enrollment
186 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

elective cardiac surgery